Business
ASX set to drop as Wall Street falls on vaccine worries – Sydney Morning Herald
The ASX’s seven-session winning streak looks in danger as a pause in Johnson & Johnson’s COVID-19 trial triggered concerns on Wall Street about the timing of a …
The Dow and the S&P 500 fell on Tuesday (US time) after a four-day winning streak as a pause in Johnson & Johnson’s COVID-19 trial triggered concerns about the timing of a vaccine, although a rally in technology shares supported the Nasdaq.
Johnson & Johnson shed 2 per cent as it said it would take “a few days” to review its halted clinical trial following an unexplained illness in a study participant, possibly delaying results on one of the most closely watched efforts to contain t…
-
Noosa News23 hours agoYou Can Save up to 43% on Power with BLUETTI’s EOFY Sale
-
Business20 hours agoAustal share price smashes new record high as takeover rumours swirl again
-
Business21 hours agoIs Google the cheapest “Magnificent Seven” stock you can buy today?
-
Noosa News21 hours agoMore than 250kg of cocaine found in Brisbane shipping container as police foil $82 million drug plot